Nectero Medical
Matthew Leyden is an experienced professional in the biopharmaceutical industry, currently serving as the Director of CMC/Regulatory at Nectero Medical, Inc. Previously, Matthew held the position of Associate Director of Project Management at Spruce Biosciences and served as Associate Director of Program Management at Tempero Bio. Matthew has also contributed to Xoc Pharmaceuticals, Inc. as a Senior Product Development Manager and Intarcia Therapeutics, Inc. as a Senior Project Manager in Product Development.
This person is not in any teams
This person is not in any offices
Nectero Medical
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.